EarningsQ2 2025 Earnings Report

BeOne Medicines (49BA) Q2 2025 Earnings Report

4 Followers

DE:49BA Q2 2025 EPS Results

Actual EPS€0.81

Consensus EPS€0.35

Beat/MissBeat by +€0.47

One Year Ago EPS-€1.03

Actual Revenue€1.18B

Expected Revenue€1.11B

Beat/MissBeat by +€70.74M

YoY Revenue Growth+42.23%

QuarterQ2 2025

Date08/06/2025

TimeBefore Open

Conference CallWednesday, August 6, 2025

DE:49BA Upcoming Earnings

BeOne Medicines's next earnings date is estimated for November 6, 2026, based on past reporting schedules.

DE:49BA Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 06, 2026	2026 (Q3)	1.70 / -	0.973	―
Aug 05, 2026	2026 (Q2)	1.48 / 1.83	0.812	125.27% (+1.02)
May 06, 2026	2026 (Q1)	0.86 / 1.75	0	―
Feb 26, 2026	2025 (Q4)	1.11 / 0.54	-1.276	141.96% (+1.81)
Nov 06, 2025	2025 (Q3)	0.76 / 0.97	-1.026	194.78% (+2.00)
Aug 06, 2025	2025 (Q2)	0.35 / 0.81	-1.026	179.13% (+1.84)
May 07, 2025	2025 (Q1)	-0.51 / 0.00	-2.151	―
Feb 27, 2025	2024 (Q4)	-0.90 / -1.28	-3.15	59.49% (+1.87)
Nov 12, 2024	2024 (Q3)	-0.99 / -1.03	1.794	-157.21% (-2.82)
Aug 26, 2024	2024 (Q2)	-1.95 / -1.03	-3.248	68.41% (+2.22)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed